631 related articles for article (PubMed ID: 32019343)
1. Stent-Only Versus Adjunctive Balloon Angioplasty Approach for Saphenous Vein Graft Percutaneous Coronary Intervention: Insights From DIVA Trial.
Latif F; Uyeda L; Edson R; Bhatt DL; Goldman S; Holmes DR; Rao SV; Shunk K; Aggarwal K; Uretsky B; Bolad I; Ziada K; McFalls E; Irimpen A; Truong HT; Kinlay S; Papademetriou V; Velagaleti RS; Rangan BV; Mavromatis K; Shih MC; Banerjee S; Brilakis ES
Circ Cardiovasc Interv; 2020 Feb; 13(2):e008494. PubMed ID: 32019343
[TBL] [Abstract][Full Text] [Related]
2. Continued benefit from paclitaxel-eluting compared with bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) trial.
Brilakis ES; Lichtenwalter C; Abdel-karim AR; de Lemos JA; Obel O; Addo T; Roesle M; Haagen D; Rangan BV; Saeed B; Bissett JK; Sachdeva R; Voudris VV; Karyofillis P; Kar B; Rossen J; Fasseas P; Berger P; Banerjee S
JACC Cardiovasc Interv; 2011 Feb; 4(2):176-82. PubMed ID: 21349456
[TBL] [Abstract][Full Text] [Related]
3. Drug-Eluting Stents Versus Bare-Metal Stents in Saphenous Vein Graft Intervention.
Patel NJ; Bavishi C; Atti V; Tripathi A; Nalluri N; Cohen MG; Kini AS; Sharma SK; Dangas G; Bhatt DL
Circ Cardiovasc Interv; 2018 Nov; 11(11):e007045. PubMed ID: 30571204
[TBL] [Abstract][Full Text] [Related]
4. Rationale and design of the Drug-Eluting Stents vs Bare-Metal Stents in Saphenous Vein Graft Angioplasty (DIVA) Trial.
Brilakis ES; Banerjee S; Edson R; Shunk K; Goldman S; Holmes DR; Bhatt DL; Rao SV; Smith MW; Sather M; Colling C; Kar B; Nielsen L; Conner T; Wagner T; Rangan BV; Ventura B; Lu Y; Holodniy M; Shih MC
Clin Cardiol; 2017 Nov; 40(11):946-954. PubMed ID: 28841230
[TBL] [Abstract][Full Text] [Related]
5. 5-year follow-up of polytetrafluoroethylene-covered stents compared with bare-metal stents in aortocoronary saphenous vein grafts the randomized BARRICADE (barrier approach to restenosis: restrict intima to curtail adverse events) trial.
Stone GW; Goldberg S; O'Shaughnessy C; Midei M; Siegel RM; Cristea E; Dangas G; Lansky AJ; Mehran R
JACC Cardiovasc Interv; 2011 Mar; 4(3):300-9. PubMed ID: 21435608
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous Coronary Intervention of Saphenous Vein Graft.
Redfors B; Généreux P; Witzenbichler B; McAndrew T; Diamond J; Huang X; Maehara A; Weisz G; Mehran R; Kirtane AJ; Stone GW
Circ Cardiovasc Interv; 2017 May; 10(5):. PubMed ID: 28495896
[TBL] [Abstract][Full Text] [Related]
7. Comparison of long-term outcomes of drug-eluting stents and bare metal stents for saphenous vein graft stenosis.
Chakravarty T; Morrissey RP; Wertman B; Naghi J; Chou S; Goykhman P; Doctor N; Mirocha J; Forrester JS; Makkar R
Catheter Cardiovasc Interv; 2012 May; 79(6):903-9. PubMed ID: 21805570
[TBL] [Abstract][Full Text] [Related]
8. Drug-Eluting Versus Bare Metal Stents in Saphenous Vein Graft Intervention: An Updated Comprehensive Meta-Analysis of Randomized Trials.
Bhogal S; Panchal HB; Bagai J; Banerjee S; Brilakis ES; Mukherjee D; Kumar G; Shanmugasundaram M; Paul TK
Cardiovasc Revasc Med; 2019 Sep; 20(9):758-767. PubMed ID: 30503811
[TBL] [Abstract][Full Text] [Related]
9. Sealing Intermediate Nonobstructive Coronary Saphenous Vein Graft Lesions With Drug-Eluting Stents as a New Approach to Reducing Cardiac Events: A Randomized Controlled Trial.
Rodés-Cabau J; Jolly SS; Cairns J; Mansour S; L'Allier PL; Teefy PJ; Graham JJ; Le May MR; Cantor WJ; Wood D; Balasubramanian K; DeLarochellière R; Dzavik V;
Circ Cardiovasc Interv; 2016 Nov; 9(11):. PubMed ID: 27815344
[TBL] [Abstract][Full Text] [Related]
10. Follow-up results after interventional treatment of infarct-related saphenous vein graft occlusion.
Hoffmann R; Nitendo G; Deserno V; Adamu U; Almalla M; Blindt R; Vogt F
Coron Artery Dis; 2010 Mar; 21(2):61-4. PubMed ID: 20124993
[TBL] [Abstract][Full Text] [Related]
11. Outcomes with drug-eluting versus bare-metal stents in saphenous vein graft intervention results from the STENT (strategic transcatheter evaluation of new therapies) group.
Brodie BR; Wilson H; Stuckey T; Nussbaum M; Laurent S; Bradshaw B; Humphrey A; Metzger C; Hermiller J; Krainin F; Juk S; Cheek B; Duffy P; Simonton CA;
JACC Cardiovasc Interv; 2009 Nov; 2(11):1105-12. PubMed ID: 19926052
[TBL] [Abstract][Full Text] [Related]
12. Drug eluting versus bare metal stents for percutaneous coronary intervention of saphenous vein graft lesions: An updated meta-analysis of randomized controlled trials.
Ha FJ; Nogic J; Montone RA; Cameron JD; Nerlekar N; Brown AJ
Cardiovasc Revasc Med; 2018; 19(7 Pt B):837-844. PubMed ID: 29685385
[TBL] [Abstract][Full Text] [Related]
13. Clinical presentation and angiographic characteristics of saphenous vein graft failure after stenting: insights from the SOS (stenting of saphenous vein grafts) trial.
Lichtenwalter C; de Lemos JA; Roesle M; Obel O; Holper EM; Haagen D; Saeed B; Iturbe JM; Shunk K; Bissett JK; Sachdeva R; Voudris VV; Karyofillis P; Kar B; Rossen J; Fasseas P; Berger P; Banerjee S; Brilakis ES
JACC Cardiovasc Interv; 2009 Sep; 2(9):855-60. PubMed ID: 19778774
[TBL] [Abstract][Full Text] [Related]
14. Differential 1-year clinical outcomes for ST-segment elevation myocardial infarction related to stent thrombosis or saphenous vein graft thrombosis.
Arzamendi D; Ly HQ; Tanguay JF; Armero S; Jilaihawi H; Gallo R; Ibrahim R; L'Allier P; Blondeau L; Gosselin G; Gregoire J; Doucet S
Catheter Cardiovasc Interv; 2013 Aug; 82(2):193-200. PubMed ID: 21805615
[TBL] [Abstract][Full Text] [Related]
15. Long term follow-up of drug eluting versus bare metal stents in the treatment of saphenous vein graft lesions.
Ybarra LF; Ribeiro HB; Pozetti AH; Campos CA; Esper RB; Lemos PA; Lopes AC; Kalil-Filho R; Ellis SG; Ribeiro EE
Catheter Cardiovasc Interv; 2013 Dec; 82(7):E856-63. PubMed ID: 23239630
[TBL] [Abstract][Full Text] [Related]
16. Impact of chronic renal insufficiency on clinical outcomes in patients undergoing saphenous vein graft intervention with drug-eluting stents: a multicenter Southern Californian Registry.
Lee MS; Hu PP; Aragon J; Shah A; Bhatia R; Jones N; Penny W; French W; Tobis J; Mahmud E
Catheter Cardiovasc Interv; 2010 Aug; 76(2):272-8. PubMed ID: 20623716
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Results After Drug-Eluting Versus Bare-Metal Stent Implantation in Saphenous Vein Grafts: Randomized Controlled Trial.
Fahrni G; Farah A; Engstrøm T; Galatius S; Eberli F; Rickenbacher P; Conen D; Mueller C; Pfister O; Twerenbold R; Coslovsky M; Cattaneo M; Kaiser C; Mangner N; Schuler G; Pfisterer M; Möbius-Winkler S; Jeger RV;
J Am Heart Assoc; 2020 Oct; 9(20):e017434. PubMed ID: 33032485
[TBL] [Abstract][Full Text] [Related]
18. Outcomes after implantation of the TAXUS paclitaxel-eluting stent in saphenous vein graft lesions: results from the ARRIVE (TAXUS Peri-Approval Registry: A Multicenter Safety Surveillance) program.
Brilakis ES; Lasala JM; Cox DA; Berger PB; Bowman TS; Starzyk RM; Dawkins KD
JACC Cardiovasc Interv; 2010 Jul; 3(7):742-50. PubMed ID: 20650436
[TBL] [Abstract][Full Text] [Related]
19. The short- and long-term outcomes of percutaneous intervention with drug-eluting stent vs bare-metal stent in saphenous vein graft disease: An updated meta-analysis of all randomized clinical trials.
Kheiri B; Osman M; Abdalla A; Ahmed S; Bachuwa G; Hassan M
Clin Cardiol; 2018 May; 41(5):685-692. PubMed ID: 29749621
[TBL] [Abstract][Full Text] [Related]
20. Drug-eluting stents versus bare-metal stents in saphenous vein grafts: a double-blind, randomised trial.
Brilakis ES; Edson R; Bhatt DL; Goldman S; Holmes DR; Rao SV; Shunk K; Rangan BV; Mavromatis K; Ramanathan K; Bavry AA; Garcia S; Latif F; Armstrong E; Jneid H; Conner TA; Wagner T; Karacsonyi J; Uyeda L; Ventura B; Alsleben A; Lu Y; Shih MC; Banerjee S;
Lancet; 2018 May; 391(10134):1997-2007. PubMed ID: 29759512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]